R&G PharmaStudies Co

R&G PharmaStudies Co Financial Leverage

The Financial Leverage (Equity Multiplier) of R&G PharmaStudies Co (301333.SZ) as of Nov 19, 2026 is 1.22. In the previous year, Financial Leverage (Equity Multiplier) was 1.27 — a change of -4.37% (lower).

Financial Leverage

1.22

YoY

-4.37%

Last updated:

Financial Leverage (Equity Multiplier) of R&G PharmaStudies Co is 2025 1.22 . Financial Leverage (Equity Multiplier) of R&G PharmaStudies Co was 2024 1.27 . It decreases by -4.37% lower compared to the previous year.

The R&G PharmaStudies Co Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2019
1.88 CNY
Jan 1, 2020
1.66 CNY
Jan 1, 2021
1.60 CNY
Jan 1, 2022
1.19 CNY
Jan 1, 2023
1.19 CNY
Jan 1, 2024
1.27 CNY
Jan 1, 2025
1.22 CNY
The R&G PharmaStudies Co Financial Leverage history
YEARFinancial LeverageYoY
1.22-4.37%
1.27+7.48%
1.19+0.01%
1.19-26.03%
1.60-3.49%
1.66-11.61%
1.88—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

R&G PharmaStudies Co Stock analysis

What does R&G PharmaStudies Co do? R&G PharmaStudies Co Ltd, based in Beijing, China, provides clinical trial outsourcing services within the Health Care sector. The company offers a range of services including clinical trial operations, site management, biological sample testing, data management, statistical analysis, consulting, and clinical pharmacology. With 1,926 employees, it operates primarily in the domestic Chinese market and was listed on the stock market on 2 August 2022. R&G PharmaStudies Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about R&G PharmaStudies Co stock

Financial Leverage (Equity Multiplier) of R&G PharmaStudies Co is 1.22 in 2025.

Financial Leverage (Equity Multiplier) of R&G PharmaStudies Co changed from 1.27 to 1.22, representing a -4.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) R&G PharmaStudies Co since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s R&G PharmaStudies Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — R&G PharmaStudies Co

All Key Metrics — R&G PharmaStudies Co